Sign in to fuzzto save your conversations, follow your research and come back anytime.
EID Parry (India) Limited is an Indian company established in 1900, headquartered in Chennai. It operates in sugar production, nutraceuticals, and bio pesticides. The company has 6 sugar factories with a total cane crushing capacity of 40,300 tonnes per day, 140 MW power generation capacity, and 5 distilleries producing 417 KLPD. EID Parry produces various sugar products, ethanol, and cogenerated power. Its nutraceuticals division focuses on organic products for global markets. The company has a subsidiary, Coromandel International Limited, for farm inputs business. EID Parry also produces bio pesticides, including neem extract Azadirachtins. The company serves pharmaceutical, confectionery, and food industries, selling products domestically and internationally. It has expanded into ethanol production and launched sanitizer products in response to market demands.
Company insights, generated from the most recent coverage.
Capital efficiency is the un-priced part of the story: FY26 ROCE of 89% and ROE of 16.5% are multiples of the Fertilizers & Agrochemicals sub-sector medians (16.9% and 9.5%), yet the stock trades at 12.4x P/E versus a 26.5x median. The market is pricing it as a cyclical sugar-linked conglomerate, not on the returns the consolidated business actually earns.
Institutional positioning is quietly rotating: DII holding rose to 20.54% from 16.75% over two quarters while FII fell to 9.63% from 12.21%, with promoters steady at 41.28%. Domestic money is accumulating into a stock that foreign investors are exiting after a 37% one-year drawdown.
Zero dividend yield removes the only reason a value buyer would hold through the earnings decline. At 1.27x book with no payout, the entire thesis rests on the balance sheet actions actually re-rating the multiple.
The Quarter story
The two most recent quarterly results, compared side-by-side.
EID Parry posts a strong profit turnaround and volume growth in sugar and consumer products, but faces mounting finance costs and margin pressure in co-generation.
Consolidated Profit Before Tax turns from a loss of ₹7,334 Cr in Q3 FY26 to a profit of ₹42,286 Cr in Q1 FY27, marking a strong financial turnaround.
Consolidated EBITDA falls from ₹3.10 Cr in Q1 FY26 to a loss of ₹4,810 Cr in Q1 FY27, reflecting severe operational strain.
Consolidated Revenue from Operations grows from ₹106 Cr in Q1 FY26 to ₹73,312 Cr in Q1 FY27, confirming sustained core demand.
Consolidated Finance Cost worsens from ₹36 Cr in Q1 FY26 to ₹11,473 Cr in Q1 FY27, highlighting rising debt burdens.
Sugar Sales Volume expands from 0.84 MT in Q1 FY26 to 88.80 MT in Q1 FY27, indicating massive volume growth.
Co-Generation Segment Result swings from a profit of ₹234 Cr in Q3 FY26 to a loss of ₹2,193 Cr in Q1 FY27, signaling margin pressure.
Ethanol Production Volume increases from 929 litres in Q2 FY26 to 1,048 litres in Q4 FY26, demonstrating consistent scaling.
Consumer Products Realization drops from ₹79.05 in Q1 FY26 to ₹51.2 in Q1 FY27, showing pricing instability.
Consumer Products Volume rises from 8,569 MT in Q1 FY26 to 14,213 MT in Q1 FY27, reflecting steady market penetration.
Sugar Gross Recovery peaks at 11.19% in Q4 FY26 but falls to 7.95% in Q1 FY27, reflecting seasonal efficiency swings.